Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.

Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M; SHIP Study Group.

Lancet Respir Med. 2019 Jun 6. pii: S2213-2600(19)30187-0. doi: 10.1016/S2213-2600(19)30187-0. [Epub ahead of print]

PMID:
31178421
2.

Development and External Validation of 1- and 2- year Mortality Prediction Models in Cystic Fibrosis.

Stanojevic S, Sykes J, Stephenson AL, Aaron SD, Whitmore GA.

Eur Respir J. 2019 May 16. pii: 1900224. doi: 10.1183/13993003.00224-2019. [Epub ahead of print]

PMID:
31097523
3.

Incidence and risk factors of paediatric cystic fibrosis-related diabetes.

Perrem L, Stanojevic S, Solomon M, Carpenter S, Ratjen F.

J Cyst Fibros. 2019 May 6. pii: S1569-1993(19)30074-8. doi: 10.1016/j.jcf.2019.04.015. [Epub ahead of print]

PMID:
31072797
4.

Linking COPD epidemiology with pediatric asthma care: Implications for the patient and the physician.

Melén E, Guerra S, Hallberg J, Jarvis D, Stanojevic S.

Pediatr Allergy Immunol. 2019 Apr 10. doi: 10.1111/pai.13054. [Epub ahead of print]

PMID:
30968967
5.

The Effect of Oral Azithromycin on the Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis.

Klingel M, Stanojevic S, Tullis E, Ratjen F, Waters V.

Ann Am Thorac Soc. 2019 Mar 15. doi: 10.1513/AnnalsATS.201811-774OC. [Epub ahead of print]

PMID:
30874447
6.

The Global Lung Function Initiative (GLI) Network ERS Clinical Research Collaboration: how international collaboration can shape clinical practice.

Hall GL, Stanojevic S; GLI Network Executive; Members of the GLI Network Executive:.

Eur Respir J. 2019 Jan 31;53(2). pii: 1802277. doi: 10.1183/13993003.02277-2018. Print 2019 Feb. No abstract available.

PMID:
30760545
7.

In vitro digestion of meat- and cereal-based food matrix enriched with grape extracts: How are polyphenol composition, bioaccessibility and antioxidant activity affected?

Pešić MB, Milinčić DD, Kostić AŽ, Stanisavljević NS, Vukotić GN, Kojić MO, Gašić UM, Barać MB, Stanojević SP, Popović DA, Banjac NR, Tešić ŽL.

Food Chem. 2019 Jun 30;284:28-44. doi: 10.1016/j.foodchem.2019.01.107. Epub 2019 Jan 23.

PMID:
30744859
8.

Does the multiple-breath washout test need to be measured before spirometry?

Au JWY, McDonald R, Stanojevic S, Ratjen F.

ERJ Open Res. 2019 Feb 4;5(1). pii: 00230-2018. doi: 10.1183/23120541.00230-2018. eCollection 2019 Feb.

9.

Mycotoxins and Mycotoxin Producing Fungi in Pollen: Review.

Kostić AŽ, Milinčić DD, Petrović TS, Krnjaja VS, Stanojević SP, Barać MB, Tešić ŽL, Pešić MB.

Toxins (Basel). 2019 Jan 24;11(2). pii: E64. doi: 10.3390/toxins11020064. Review.

10.

Phytochemical Analysis and Total Antioxidant Capacity of Rhizome, Above-Ground Vegetative Parts and Flower of Three Iris Species.

Kostić AŽ, Gašić UM, Pešić MB, Stanojević SP, Barać MB, Mačukanović-Jocić MP, Avramov SN, Tešić ŽL.

Chem Biodivers. 2019 Mar;16(3):e1800565. doi: 10.1002/cbdv.201800565. Epub 2019 Feb 28.

PMID:
30609204
11.

Cluster and CART analyses identify large subgroups of adults with cystic fibrosis at low risk of 10-year death.

Burgel PR, Lemonnier L, Dehillotte C, Sykes J, Stanojevic S, Stephenson AL, Paillasseur JL.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801943. doi: 10.1183/13993003.01943-2018. Print 2019 Mar.

PMID:
30578399
12.

The involvement of estrogen receptors α and β in the in vitro effects of 17β-estradiol on secretory profile of peritoneal macrophages from naturally menopausal female and middle-aged male rats.

Stanojević S, Ćuruvija I, Blagojević V, Petrović R, Prijić I, Vujić V.

Exp Gerontol. 2018 Nov;113:86-94. doi: 10.1016/j.exger.2018.09.024. Epub 2018 Oct 1.

PMID:
30287187
13.

All-Loop Singularities of Scattering Amplitudes in Massless Planar Theories.

Prlina I, Spradlin M, Stanojevic S.

Phys Rev Lett. 2018 Aug 24;121(8):081601. doi: 10.1103/PhysRevLett.121.081601.

PMID:
30192603
14.

Interpretation of Spirometry in Saskatchewan First Nations Adults.

Fenton ME, Graham BL, Stanojevic S, Whitford L, Ironstand L.

Ann Am Thorac Soc. 2018 Oct;15(10):1237-1239. doi: 10.1513/AnnalsATS.201711-909RL. No abstract available.

PMID:
29949379
15.

Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population.

Middleton MA, Layeghifard M, Klingel M, Stanojevic S, Yau YCW, Zlosnik JEA, Coriati A, Ratjen FA, Tullis ED, Stephenson A, Wilcox P, Freitag A, Chilvers M, McKinney M, Lavoie A, Wang PW, Guttman DS, Waters VJ.

Ann Am Thorac Soc. 2018 Jul;15(7):827-836. doi: 10.1513/AnnalsATS.201801-007OC.

PMID:
29911888
16.

Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?

Avila ML, Amiri N, Stanojevic S, Vu TT, Barron K, Krol P, Yue N, Williams S, Brandão LR.

Blood. 2018 Jun 14;131(24):2712-2719. doi: 10.1182/blood-2017-10-811216. Epub 2018 May 3.

17.

The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF.

Eckford PDW, McCormack J, Munsie L, He G, Stanojevic S, Pereira SL, Ho K, Avolio J, Bartlett C, Yang JY, Wong AP, Wellhauser L, Huan LJ, Jiang JX, Ouyang H, Du K, Klingel M, Kyriakopoulou L, Gonska T, Moraes TJ, Strug LJ, Rossant J, Ratjen F, Bear CE.

J Cyst Fibros. 2019 Jan;18(1):35-43. doi: 10.1016/j.jcf.2018.03.013. Epub 2018 Oct 10.

18.

Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment.

Blanchard AC, Rooney AM, Yau Y, Zhang Y, Stapleton PJ, Horton E, Klingel M, Stanojevic S, Ratjen F, Coburn B, Waters V.

J Cyst Fibros. 2018 Nov;17(6):723-728. doi: 10.1016/j.jcf.2018.02.008. Epub 2018 Mar 7.

PMID:
29525410
19.

Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement.

Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, Singer F, Subbarao P, Gustafsson PM, Ratjen F; ATS Assembly on Pediatrics.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):e1-e19. doi: 10.1164/rccm.201801-0074ST.

PMID:
29493315
20.

Comparison of facemask and mouthpiece interfaces for multiple breath washout measurements.

Robinson PD, Lum S, Moore C, Hardaker KM, Benseler N, Aurora P, Cooper P, Fitzgerald D, Jensen R, McDonald R, Selvadurai H, Ratjen F, Stanojevic S.

J Cyst Fibros. 2018 Jul;17(4):511-517. doi: 10.1016/j.jcf.2018.01.003. Epub 2018 Mar 2.

PMID:
29483003
21.

Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis.

Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F.

Thorax. 2018 May;73(5):451-458. doi: 10.1136/thoraxjnl-2017-210979. Epub 2018 Feb 15.

PMID:
29449440
22.

Rat strain differences in peritoneal immune cell response to selected gut microbiota: A crossroad between tolerance and autoimmunity?

Blagojević V, Kovačević-Jovanović V, Ćuruvija I, Petrović R, Vujnović I, Vujić V, Stanojević S.

Life Sci. 2018 Mar 15;197:147-157. doi: 10.1016/j.lfs.2018.02.011. Epub 2018 Feb 8.

PMID:
29427649
23.

A guide to interpreting estimated median age of survival in cystic fibrosis patient registry reports.

Keogh RH, Stanojevic S.

J Cyst Fibros. 2018 Mar;17(2):213-217. doi: 10.1016/j.jcf.2017.11.014. Epub 2018 Feb 2.

24.

Clinical characteristics of cystic fibrosis patients prior to lung transplantation: An international comparison between Canada and the United States.

Quon BS, Sykes J, Stanojevic S, Marshall BC, Petren K, Ostrenga J, Fink A, Elbert A, Faro A, Goss CH, Stephenson AL.

Clin Transplant. 2018 Mar;32(3):e13188. doi: 10.1111/ctr.13188. Epub 2018 Feb 11.

25.

Standardisation of lung function test interpretation: Global Lung Function Initiative.

Stanojevic S.

Lancet Respir Med. 2018 Jan;6(1):10-12. doi: 10.1016/S2213-2600(17)30472-1. Epub 2017 Dec 7. No abstract available.

PMID:
29226810
26.

Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.

Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472. doi: 10.1164/rccm.201710-1981ST.

PMID:
29192835
27.

Low lung function in early adulthood: morbidity and death.

Taylor-Robinson DC, Stanojevic S.

Lancet Respir Med. 2017 Dec;5(12):910-911. doi: 10.1016/S2213-2600(17)30437-X. Epub 2017 Nov 14. No abstract available.

PMID:
29150409
28.

Comparison of Nutrition and Lung Function Outcomes in Patients with Cystic Fibrosis Living in Canada and the United States.

Goss CH, Sykes J, Stanojevic S, Marshall B, Petren K, Ostrenga J, Fink A, Elbert A, Quon BS, Stephenson AL.

Am J Respir Crit Care Med. 2018 Mar 15;197(6):768-775. doi: 10.1164/rccm.201707-1541OC.

29.

Data Resource Profile: The UK Cystic Fibrosis Registry.

Taylor-Robinson D, Archangelidi O, Carr SB, Cosgriff R, Gunn E, Keogh RH, MacDougall A, Newsome S, Schlüter DK, Stanojevic S, Bilton D; CF-EpinNet collaboration.

Int J Epidemiol. 2018 Feb 1;47(1):9-10e. doi: 10.1093/ije/dyx196. No abstract available.

30.

Correcting for tissue nitrogen excretion in multiple breath washout measurements.

Kane M, Rayment JH, Jensen R, McDonald R, Stanojevic S, Ratjen F.

PLoS One. 2017 Oct 11;12(10):e0185553. doi: 10.1371/journal.pone.0185553. eCollection 2017.

31.

Inter-test reproducibility of the lung clearance index measured by multiple breath washout.

Oude Engberink E, Ratjen F, Davis SD, Retsch-Bogart G, Amin R, Stanojevic S.

Eur Respir J. 2017 Oct 5;50(4). pii: 1700433. doi: 10.1183/13993003.00433-2017. Print 2017 Oct.

32.

The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together.

Cooper BG, Stocks J, Hall GL, Culver B, Steenbruggen I, Carter KW, Thompson BR, Graham BL, Miller MR, Ruppel G, Henderson J, Vaz Fragoso CA, Stanojevic S.

Breathe (Sheff). 2017 Sep;13(3):e56-e64. doi: 10.1183/20734735.012717. Review.

33.

Can epidemiological studies determine the productivity-related burden of COPD?

Stanojevic S.

Eur Respir J. 2017 Sep 20;50(3). pii: 1701515. doi: 10.1183/13993003.01515-2017. Print 2017 Sep. No abstract available.

34.

Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.

Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, Hall GL; Global Lung Function Initiative TLCO working group; Global Lung Function Initiative (GLI) TLCO.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700010. doi: 10.1183/13993003.00010-2017. Print 2017 Sep.

35.

Interpretation of Cystic Fibrosis Centre rankings: Meaningful comparisons or biased statistics?

Stanojevic S.

J Cyst Fibros. 2017 Sep;16(5):534-535. doi: 10.1016/j.jcf.2017.07.020. Epub 2017 Aug 4. No abstract available.

PMID:
28781231
36.

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.

Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies JC; VX14-809-109 investigator group.

Lancet Respir Med. 2017 Jul;5(7):557-567. doi: 10.1016/S2213-2600(17)30215-1. Epub 2017 Jun 9. Erratum in: Lancet Respir Med. 2017 Aug;5(8):e28.

37.

The changing epidemiology and demography of cystic fibrosis.

Stephenson AL, Stanojevic S, Sykes J, Burgel PR.

Presse Med. 2017 Jun;46(6 Pt 2):e87-e95. doi: 10.1016/j.lpm.2017.04.012. Epub 2017 May 26.

PMID:
28554720
38.

Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.

Somayaji R, Stanojevic S, Tullis DE, Stephenson AL, Ratjen F, Waters V.

Ann Am Thorac Soc. 2017 Sep;14(9):1412-1418. doi: 10.1513/AnnalsATS.201701-071OC.

PMID:
28406714
39.

Sex Differences in Macrophage Functions in Middle-Aged Rats: Relevance of Estradiol Level and Macrophage Estrogen Receptor Expression.

Ćuruvija I, Stanojević S, Arsenović-Ranin N, Blagojević V, Dimitrijević M, Vidić-Danković B, Vujić V.

Inflammation. 2017 Jun;40(3):1087-1101. doi: 10.1007/s10753-017-0551-3.

PMID:
28353029
40.

Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Stephenson AL, Sykes J, Stanojevic S, Quon BS, Marshall BC, Petren K, Ostrenga J, Fink AK, Elbert A, Goss CH.

Ann Intern Med. 2017 Apr 18;166(8):537-546. doi: 10.7326/M16-0858. Epub 2017 Mar 14.

41.

A clinical tool to calculate post-transplant survival using pre-transplant clinical characteristics in adults with cystic fibrosis.

Stephenson AL, Sykes J, Berthiaume Y, Singer LG, Chaparro C, Aaron SD, Whitmore GA, Stanojevic S.

Clin Transplant. 2017 Jun;31(6). doi: 10.1111/ctr.12950. Epub 2017 Apr 23.

PMID:
28267234
42.

Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.

Blanchard AC, Horton E, Stanojevic S, Taylor L, Waters V, Ratjen F.

J Cyst Fibros. 2017 May;16(3):395-400. doi: 10.1016/j.jcf.2017.01.007. Epub 2017 Feb 9.

43.

Validation of multiple breath washout devices.

Raaijmakers L, Jensen R, Stanojevic S, Ratjen F.

J Cyst Fibros. 2017 Nov;16(6):e22-e23. doi: 10.1016/j.jcf.2017.01.011. Epub 2017 Feb 7. No abstract available.

PMID:
28185888
44.

Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N.

J Cyst Fibros. 2017 May;16(3):318-326. doi: 10.1016/j.jcf.2017.01.002. Epub 2017 Jan 20. Review.

45.

Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.

Stanojevic S, Davis SD, Retsch-Bogart G, Webster H, Davis M, Johnson RC, Jensen R, Pizarro ME, Kane M, Clem CC, Schornick L, Subbarao P, Ratjen FA.

Am J Respir Crit Care Med. 2017 May 1;195(9):1216-1225. doi: 10.1164/rccm.201610-2158OC.

46.

Clinimetric Properties of the Lung Clearance Index in Adults and Children With Cystic Fibrosis.

Oude Engberink E, Stanojevic S, Ratjen F.

Chest. 2016 Dec;150(6):1412-1413. doi: 10.1016/j.chest.2016.08.1478. No abstract available.

PMID:
27938756
47.

Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population.

Langhammer A, Johannessen A, Holmen TL, Melbye H, Stanojevic S, Lund MB, Melsom MN, Bakke P, Quanjer PH.

Eur Respir J. 2016 Dec;48(6):1602-1611. doi: 10.1183/13993003.00443-2016. Epub 2016 Oct 6.

48.

Do the Global Lung Function Initiative 2012 equations fit my population?

Quanjer PH, Stanojevic S.

Eur Respir J. 2016 Dec;48(6):1782-1785. doi: 10.1183/13993003.01757-2016. Epub 2016 Nov 3. No abstract available.

49.

Strain-dependent response to stimulation in middle-aged rat macrophages: A quest after a useful indicator of healthy aging.

Stanojević S, Ćuruvija I, Blagojević V, Petrović R, Vujić V, Dimitrijević M.

Exp Gerontol. 2016 Dec 1;85:95-107. doi: 10.1016/j.exger.2016.10.005. Epub 2016 Oct 15.

PMID:
27756630
50.

Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis.

Waters V, Stanojevic S, Ratjen F.

Expert Rev Respir Med. 2016 Nov;10(11):1221-1228. doi: 10.1080/17476348.2017.1246963. Epub 2016 Oct 20.

PMID:
27718754

Supplemental Content

Loading ...
Support Center